{"entity":{"type":"insider","cik":"0001683811","url":"/insider/0001683811","json_url":"/insider/0001683811.json","name":"Sacks Natalie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":19,"first":"2017-09-06","last":"2020-05-20","span_basis":"filed_date"},"name_variants":[{"name":"Sacks Natalie","source":"filing","n_filings":19,"first_seen":"2017-09-06","last_seen":"2020-05-20"}],"transactions":[{"id":3277953,"accession":"0001209191-20-031019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-031019","line_url":"/filing/0001209191-20-031019#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1522.0,"shares_display":"1,522","price_per_share":14.7691,"price_display":"14.77","price_state":"stated","total_value":22478.5702,"total_display":"22,478.57","total_whole":"22,479","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":3312437,"accession":"0001209191-20-027143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-027143","line_url":"/filing/0001209191-20-027143#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":12.0668,"price_display":"12.07","price_state":"stated","total_value":70301.1768,"total_display":"70,301.18","total_whole":"70,301","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-01","filed_date":"2020-05-05","scope":"insider"},{"id":2509184,"accession":"0001209191-20-024947","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-024947","line_url":"/filing/0001209191-20-024947#line-4","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1021.0,"shares_display":"1,021","price_per_share":12.0765,"price_display":"12.08","price_state":"stated","total_value":12330.1065,"total_display":"12,330.11","total_whole":"12,330","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-17","filed_date":"2020-04-17","scope":"insider"},{"id":2509178,"accession":"0001209191-20-024947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-024947","line_url":"/filing/0001209191-20-024947#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-17","scope":"insider"},{"id":2040677,"accession":"0001209191-20-024489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-024489","line_url":"/filing/0001209191-20-024489#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4556.0,"shares_display":"4,556","price_per_share":12.063,"price_display":"12.06","price_state":"stated","total_value":54959.028,"total_display":"54,959.03","total_whole":"54,959","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-15","scope":"insider"},{"id":2584639,"accession":"0001209191-20-023954","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-023954","line_url":"/filing/0001209191-20-023954#line-4","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":570.0,"shares_display":"570","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":6840.0,"total_display":"6,840.00","total_whole":"6,840","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-07","filed_date":"2020-04-08","scope":"insider"},{"id":2584627,"accession":"0001209191-20-023954","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-023954","line_url":"/filing/0001209191-20-023954#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":12.0014,"price_display":"12.00","price_state":"stated","total_value":8400.98,"total_display":"8,400.98","total_whole":"8,401","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-06","filed_date":"2020-04-08","scope":"insider"},{"id":2543201,"accession":"0001209191-20-020052","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-020052","line_url":"/filing/0001209191-20-020052#line-4","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1520.0,"shares_display":"1,520","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":18240.0,"total_display":"18,240.00","total_whole":"18,240","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-18","scope":"insider"},{"id":2543195,"accession":"0001209191-20-020052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-020052","line_url":"/filing/0001209191-20-020052#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":12.0,"total_display":"12.00","total_whole":"12","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-03-18","scope":"insider"},{"id":2245244,"accession":"0001209191-20-015855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-015855","line_url":"/filing/0001209191-20-015855#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":14.68,"price_display":"14.68","price_state":"stated","total_value":85525.68,"total_display":"85,525.68","total_whole":"85,526","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-03","scope":"insider"},{"id":3276641,"accession":"0001209191-20-011190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-011190","line_url":"/filing/0001209191-20-011190#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":22815.0,"total_display":"22,815.00","total_whole":"22,815","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-18","filed_date":"2020-02-20","scope":"insider"},{"id":2820729,"accession":"0001209191-20-006706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-006706","line_url":"/filing/0001209191-20-006706#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":13.9043,"price_display":"13.90","price_state":"stated","total_value":81006.4518,"total_display":"81,006.45","total_whole":"81,006","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":2283188,"accession":"0001209191-20-004374","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-004374","line_url":"/filing/0001209191-20-004374#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":14.9408,"price_display":"14.94","price_state":"stated","total_value":22724.9568,"total_display":"22,724.96","total_whole":"22,725","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-16","filed_date":"2020-01-21","scope":"insider"},{"id":3146555,"accession":"0001209191-20-002179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-002179","line_url":"/filing/0001209191-20-002179#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":14.1779,"price_display":"14.18","price_state":"stated","total_value":82600.4454,"total_display":"82,600.45","total_whole":"82,600","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":7885838,"accession":"0001209191-19-061097","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-061097","line_url":"/filing/0001209191-19-061097#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1521.0,"shares_display":"1,521","price_per_share":17.0201,"price_display":"17.02","price_state":"stated","total_value":25887.5721,"total_display":"25,887.57","total_whole":"25,888","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-16","filed_date":"2019-12-18","scope":"insider"},{"id":7873414,"accession":"0001209191-19-059085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059085","line_url":"/filing/0001209191-19-059085#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":17.98,"price_display":"17.98","price_state":"stated","total_value":104751.48,"total_display":"104,751.48","total_whole":"104,751","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8210281,"accession":"0001209191-19-057167","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-057167","line_url":"/filing/0001209191-19-057167","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18252.0,"shares_display":"18,252","price_per_share":13.366424742493972,"price_display":"13.37","price_state":"stated","total_value":243963.9844,"total_display":"243,963.98","total_whole":"243,964","shares_owned_after":46754.0,"shares_owned_after_display":"46,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-18","filed_date":"2019-11-19","scope":"insider","n_lines":2},{"id":7928698,"accession":"0001209191-19-055169","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-055169","line_url":"/filing/0001209191-19-055169#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5826.0,"shares_display":"5,826","price_per_share":13.1654,"price_display":"13.17","price_state":"stated","total_value":76701.6204,"total_display":"76,701.62","total_whole":"76,702","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-01","filed_date":"2019-11-05","scope":"insider"},{"id":7928482,"accession":"0001209191-19-053306","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-053306","line_url":"/filing/0001209191-19-053306#line-4","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11698.0,"shares_display":"11,698","price_per_share":13.2058,"price_display":"13.21","price_state":"stated","total_value":154481.4484,"total_display":"154,481.45","total_whole":"154,481","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-16","scope":"insider"},{"id":7928476,"accession":"0001209191-19-053306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-053306","line_url":"/filing/0001209191-19-053306#line-2","is_derivative":false,"issuer_cik":"0001683811","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001683811","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12452.0,"shares_display":"12,452","price_per_share":13.2734,"price_display":"13.27","price_state":"stated","total_value":165280.3768,"total_display":"165,280.38","total_whole":"165,280","shares_owned_after":45754.0,"shares_owned_after_display":"45,754","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-14","filed_date":"2019-10-16","scope":"insider"},{"id":6102936,"accession":"0001567619-18-002681","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-18-002681","line_url":"/filing/0001567619-18-002681#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3028.0,"shares_display":"3,028","price_per_share":6.4993,"price_display":"6.50","price_state":"stated","total_value":19679.8804,"total_display":"19,679.88","total_whole":"19,680","shares_owned_after":173720.0,"shares_owned_after_display":"173,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-13","filed_date":"2018-09-14","scope":"insider"},{"id":6597905,"accession":"0001567619-18-002235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-18-002235","line_url":"/filing/0001567619-18-002235#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4504.0,"shares_display":"4,504","price_per_share":7.1268,"price_display":"7.13","price_state":"stated","total_value":32099.1072,"total_display":"32,099.11","total_whole":"32,099","shares_owned_after":89548.0,"shares_owned_after_display":"89,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-04","filed_date":"2018-09-06","scope":"insider"},{"id":4784961,"accession":"0001209191-17-051631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-051631","line_url":"/filing/0001209191-17-051631#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"ADURO BIOTECH, INC.","issuer_ticker":"ADRO","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001683811","owner_name":"Sacks Natalie","owner_display_name":"Sacks Natalie","owner_url":"/insider/0001683811","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4885.0,"shares_display":"4,885","price_per_share":11.7085,"price_display":"11.71","price_state":"stated","total_value":57196.0225,"total_display":"57,196.02","total_whole":"57,196","shares_owned_after":45115.0,"shares_owned_after_display":"45,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Officer (Chief Medical Officer)","n_filings":16,"first_seen":"2019-10-16","last_seen":"2020-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"ADURO BIOTECH, INC.","url":"/issuer/0001435049","role":"Officer (Chief Medical Officer)","n_filings":3,"first_seen":"2017-09-06","last_seen":"2018-09-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001683811","retrieved_at":"2026-08-27T10:29:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}